COMP <GO>
CLS vs NVDA // ALTMAN Z-SCORE & DEBT/EQUITY
Celestica Inc. (NYSE) VS. NVIDIA Corporation (NASDAQ) • 15-METRIC TALLY: CLS 1
— NVDA 13
▲ ALTMAN Z-SCORE & DEBT/EQUITY LEADER: NVDA
LAST: $282.75 (-5.69%) • MKT CAP: $35.66B
balance-sheet
6.84
LAST: $213.66 (-0.80%) • MKT CAP: $5.15T
balance-sheet
19.52
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CLS VS. NVDA)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CLS | NVDA | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 12.10% | 74.67% | -62.57 | NVDA | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 22.10% | 65.06% | -42.96 | NVDA | /roic <GO> |
| EV/EBITDA & P/E Valuation | 24.5x | 23.2x | +1.29 | NVDA | /valuation <GO> |
| Free Cash Flow Yield | 0.29% | 2.58% | -2.29 | NVDA | /fcf-yield <GO> |
| Operating Margin | 8.40% | 65.21% | -56.81 | NVDA | /operating-margins <GO> |
| Net Profit Margin | 6.70% | 63.66% | -56.96 | NVDA | /net-margins <GO> |
| Revenue Growth (YoY) | 28.50% | 83.38% | -54.88 | NVDA | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.02% | -0.02 | NVDA | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity ACTIVE | 6.84 | 19.52 | -12.68 | NVDA | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 4/9 | +3.00 | CLS | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 9.01% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 43.2 | 51.1 | -7.90 | NVDA | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.42 | 2.04 | -0.62 | NVDA | /macro-sensitivity <GO> |
| Forward P/E Multiple | 36.0x | 17.0x | +18.98 | NVDA | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $35.66B | $5.15T | -$5.11T | NVDA | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CLS REV | NVDA REV | CLS GROSS % | NVDA GROSS % | CLS FCF | NVDA FCF |
|---|---|---|---|---|---|---|
| FY 2026 | — | $215.94B | — | 71.1% | — | $96.68B |
| FY 2025 | $12.39B | $130.50B | 12.1% | 75.0% | $101.9M | $60.85B |
| FY 2024 | $9.65B | $60.92B | 10.7% | 72.7% | $39.8M | $27.02B |
| FY 2023 | $7.96B | $26.97B | — | 56.9% | -$32.0M | $3.81B |
| FY 2022 | — | $26.91B | — | 64.9% | — | $8.13B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CLS // BETA 1.42
NVDA // BETA 2.04